Literature DB >> 4892452

Trimethroprim and sulfalene therapy of Plasmodium vivax.

D C Martin, J D Arnold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4892452

Source DB:  PubMed          Journal:  J Clin Pharmacol J New Drugs        ISSN： 0095-9863


× No keyword cloud information.
  5 in total

Review 1.  Antifolic combinations in the treatment of malaria.

Authors:  L Conno
Journal:  Bull World Health Organ       Date:  1974       Impact factor: 9.408

Review 2.  Trimethoprim resistance.

Authors:  P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

3.  Growth inhibition of Candida albicans by folate pathway inhibitors. Their potential in the selection of auxotrophs.

Authors:  O E Henson; D O McClary
Journal:  Antonie Van Leeuwenhoek       Date:  1979       Impact factor: 2.271

4.  Sulfadoxine resistance in Plasmodium vivax is associated with a specific amino acid in dihydropteroate synthase at the putative sulfadoxine-binding site.

Authors:  Michael Korsinczky; Katja Fischer; Nanhua Chen; Joanne Baker; Karl Rieckmann; Qin Cheng
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

Review 5.  The genomic architecture of antimalarial drug resistance.

Authors:  Annie N Cowell; Elizabeth A Winzeler
Journal:  Brief Funct Genomics       Date:  2019-09-24       Impact factor: 4.241
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.